15 results match your criteria: "Cleveland Clinic Fertility Center[Affiliation]"
Aust N Z J Obstet Gynaecol
September 2024
Department of Urology, Glickman Urological and Kidney Institute, Cleveland Clinic Foundation, Cleveland, Ohio, USA.
Reprod Biol Endocrinol
October 2022
Department of OB/GYN and Women's Health Institute, Cleveland Clinic Fertility Center, Cleveland Clinic Foundation, Beachwood, OH, USA.
Background: Encapsulation of follicles within a biomatrix is one approach to maintaining 3-D follicle architecture during culture. Hyaluronan is one component of the natural extracellular matrix (ECM) that provides support to cells in vivo. This report describes the application of a novel tyramine-linked hyaluronan for 3-D in vitro follicle culture and the production of developmentally competent metaphase II oocytes.
View Article and Find Full Text PDFBiol Open
December 2021
Zoology Department, University of Oxford, 11a Mansfield Road, Oxford, OX1 3SZ, UK.
Mouse zygote morphokinetics were measured during interphase, the mitotic period, cytokinesis, and two-cell stage. Sequences of rounder-distorted-rounder shapes were revealed, as were changing patterns of cross section area. A calcium chelator and an actin-disrupting agent inhibited the area changes that occurred between pronuclear envelope breakdown and cytokinesis.
View Article and Find Full Text PDFFertil Steril
December 2021
IVIRMA of New Jersey, Basking Ridge, New Jersey; Department of Obstetrics, Gynecology, and Reproductive Sciences, Yale School of Medicine, New Haven, Connecticut.
Fertil Steril
November 2016
Department of Obstetrics and Gynecology, Women's Health Institute, Cleveland Clinic Fertility Center, Beachwood, Ohio.
Objective: To identify blastocyst features independently predictive of successful pregnancy and live births with vitrified-warmed blastocysts.
Design: Retrospective study.
Setting: Academic hospital.
Reprod Biol Endocrinol
May 2013
Department of OB/GYN/Women's Health Institute, Cleveland Clinic Fertility Center, Beachwood, OH, USA.
Background: The Rapid-i is a new FDA cleared closed carrier for embryo vitrification. The cooling rate of - 1220°C/min is far lower than that reported with open vitrification systems such as the cryoloop (-15,000°C/min). Little published data is currently available on this device.
View Article and Find Full Text PDFJ Assist Reprod Genet
June 2013
Cleveland Clinic Fertility Center, Department of OB-GYN/Women's Health Institute, Beachwood, OH 44122, USA.
Purpose: Mouse embryonic fibroblast feeder layers (MEF) have conventionally been used to culture and maintain the pluripotency of embryonic stem cells (ESC). This study explores the potential of using a novel human endometrial cell line to develop a non-xeno, non-contact co-culture system for ESC propagation and derivation. Such xeno-free systems may prove essential for the establishment of clinical grade human ESC lines suitable for therapeutic application.
View Article and Find Full Text PDFReprod Biol Endocrinol
June 2012
Cleveland Clinic Fertility Center, Department of OB/GYN and Women's Health Institute, Cleveland Clinic Foundation, Beachwood, OH, USA.
Background: Folliculogenesis within the ovary requires interaction between somatic cell components and the oocyte. Maintenance of 3-dimensional (3-D) architecture and granulosa-oocyte interaction may be critical for successful in vitro maturation of follicles. Testing of novel biomaterials for the 3-D culture of follicles may ultimately lead to a culture model that can support the longer in vitro culture intervals needed for in vitro maturation of human oocytes from ovarian tissue biopsies.
View Article and Find Full Text PDFJ Assist Reprod Genet
May 2012
Department of OB-GYN, Cleveland Clinic Fertility Center, Beachwood, OH, USA.
Objective: To describe a new technique for freezing individually isolated spermatazoa from testicular biopsies, epididymal aspirates and oligospermic semen samples
Methods: Samples were evaluated for the presence of motile sperm before cryopreservation. Motile or twitching sperm were isolated with an ICSI needle for single sperm cryopreservation. Selected sperm were loaded on the High Security Straw (HSV; Irvine Scientific; Irvine,CA), in ~0.
BMC Biotechnol
March 2011
Cleveland Clinic Fertility Center, Department of OB/GYN and Women's Health Institute, Cleveland Clinic Foundation, USA.
Background: High cooling rates with vitrification can be achieved through the use of carriers that allow cryopreservation in fluid volumes < one μl. Open carriers allow direct contact of embryos with liquid nitrogen (LN2) whereas closed carrier systems sequester the embryo within a sealed system during immersion in LN2. The use of closed systems may be preferable to reduce the possibility of cross-contamination.
View Article and Find Full Text PDFReprod Biol Endocrinol
October 2010
Department of OB/GYN and Women's Health Institute, Cleveland Clinic Foundation, Cleveland Clinic Fertility Center, Cleveland, Ohio, USA.
In vitro ovarian follicle culture is a new frontier in assisted reproductive technology with tremendous potential, especially for fertility preservation. Folliculogenesis within the ovary is a complex process requiring interaction between somatic cell components and the oocyte. Conventional two-dimensional culture on tissue culture substrata impedes spherical growth and preservation of the spatial arrangements between oocyte and surrounding granulosa cells.
View Article and Find Full Text PDFObstet Gynecol
October 2010
From the Carolina Women's Research and Wellness Center, Durham, North Carolina; Xanodyne Pharmaceuticals, Inc., Newport, Kentucky; the Department of Obstetrics and Gynecology, University of Kentucky, Lexington, Kentucky; the New Age Medical Research Corporation, Miami, Florida; the Cleveland Clinic Fertility Center, Canfield, Ohio; the Department of Obstetrics and Gynecology, Danderyds Hospital, Stockholm, Sweden; the University of Alabama at Birmingham, Birmingham, Alabama; The Center for Women's Health & Wellness, LLC, Plainsboro, New Jersey; the University of Miami, Miami, Florida; the University of Washington, Seattle, Washington; and ARSTAT Analysis, Flemington, New Jersey.
Objective: To assess the efficacy and safety of an oral formulation of tranexamic acid for the treatment of heavy menstrual bleeding.
Methods: Adult women with heavy menstrual bleeding (mean menstrual blood loss 80 mL or more per cycle) were enrolled in a double-blind, placebo-controlled study. After two pretreatment menstrual cycles, women were randomized to receive tranexamic acid 3.
Reprod Biomed Online
June 2010
Cleveland Clinic Fertility Center, Department of OB/GYN and Women's Health Institute, Cleveland Clinic Foundation, 26900 Cedar Rd., Beachwood, OH 44122, USA.
Human embryo vitrification is a promising new technology but clinical outcome data is needed to gauge its effectiveness and safety. While pregnancy and live-birth data is available for blastocyst vitrification, such information is lacking for human embryo vitrification at the 6- to 8-cell stage. The current work presents clinical and obstetric outcomes from the transfer of embryos vitrified on day 3 at the cleavage stage.
View Article and Find Full Text PDFReprod Biol Endocrinol
December 2009
Cleveland Clinic Fertility Center, Department of Obstetrics-Gynecology, Cleveland Clinic Foundation, Beachwood, OH, USA.
Background: This study takes an in depth look at embryonic development, implantation, pregnancy and live birth rates with frozen epididymal and testicular sperm from obstructed (OA) and non-obstructed (NOA) patients.
Methods: Paternal effect of sperm source on zygote formation, embryonic cleavage, and genomic activation were examined. Additional outcome parameters monitored were clinical pregnancy rate (CPR), implantation rate (IR) and live birth rate.
J Assist Reprod Genet
June 2007
The Cleveland Clinic Fertility Center, 26900 Cedar Road, Beachwood, OH 44122, USA.
Purpose: The objective of this study was to evaluate the effects of growth factor supplementation and Vero cell co-culture on apoptosis and development of frozen thawed one-cell mouse embryos.
Methods: The following treatment regimens were assessed: (a) control medium (b) Vero cell co-culture and (c) growth factor supplemented medium. The individual growth factors tested were: GM-CSF, IGF-I, IGF-II, TNF-alpha, FGF-4, LIF, TGF-alpha, TGF-beta, IL-6, PDGF and EGF.